Rezolute, Inc.
RZLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509261
No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Rezolute, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 11 | 12 | +1 |
| Shares | 2.48M | 2.21M | −265.5K (−10.7%) |
| Value | $17.5M | $31.6M | +$14.1M (+80.5%) |
New holders (5)
Institutions that held Rezolute, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 32,124 | $459.0K | 0.00% |
| Vanguard Group Inc | 29,390 | $419.0K | 0.00% |
| BlackRock Inc. | 12,430 | $177.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 750 | $11.0K | 0.00% |
| Advisor Group Holdings, Inc. | 65 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Rezolute, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Armistice Capital, LLC | 288,000 | $2.03M |
| Millennium Management LLC | 26,924 | $190.0K |
| 683 Capital Management, LLC | 18,916 | $134.0K |
| Bank of America Corp | 475 | $3.00K |